Andrew Pollack

New York Times

Guest

Correspondent for the New York Times, covering the business and science of biotechnology

Andrew Pollack on KCRW

Mylan might or might not have good news for people who need EpiPens.

Drug-maker Mylan and its $300 "generic" EpiPen

Mylan might or might not have good news for people who need EpiPens.

from To the Point

Specialists who treat rare diseases are protesting gigantic increases in the prices of old and familiar drugs. The cost of one medicine jumped 5000 percent -- overnight.

When Drug Prices Skyrocket Overnight

Specialists who treat rare diseases are protesting gigantic increases in the prices of old and familiar drugs. The cost of one medicine jumped 5000 percent -- overnight.

from To the Point

ZMapp is an experimental drug that has shown promise as a treatment for the Ebola virus.

The Ebola Drug

ZMapp is an experimental drug that has shown promise as a treatment for the Ebola virus.

from Press Play with Madeleine Brand

More from KCRW

Fast food workers lose about 16% of their pay every year, a new Northwestern University study found.

from KCRW Features

KCRW reflects on Joe Biden’s presidential legacy. How will the tumultuous events of his term be remembered, and what moments stood out most?

from Left, Right & Center

The right says it’s pushing back on cancel culture. Are they just redefining it? Plus, the president banishes pennies and paper straws.

from Left, Right & Center

Did President Trump defy court orders with deportation flights? Can Democrats recover from historically low polling? Plus, KCRW examines The Kennedy Center culture wars.

from Left, Right & Center

Which news headlines are worth the worry? If Democrats want to raise the alarms on Trump, they’ll have to communicate. Plus, KCRW takes listener questions.

from Left, Right & Center

Were the April special elections a win for Democrats? How will Trump’s “Liberation Day” tariffs affect American consumers? Plus, KCRW discusses the feasibility of a third Trump term.

from Left, Right & Center

This is the political season to be thankful for small favors of optimism, and in this edition of Scheer Intelligence, host Robert Scheer and guest Joe Lauria, editor of the Consortium…

from Scheer Intelligence

The arrest of a student protester raises questions on free speech. Is the White House picking which speech is illegal, or are they enforcing anti-discrimination laws?

from Left, Right & Center

Hundreds gathered in immigrant-dense Santa Ana to protest the Trump administration’s deportation plans after a similar movement closed the 101 freeway in Downtown LA.

from KCRW Features